Fatty Acids and Executive Function Development in 7-12 Year Olds
1 other identifier
observational
79
1 country
1
Brief Summary
Purpose: To examine the effect of the omega-6 to omega-3 fatty acid ratio on age-related changes in executive functions in children and older adults. Participants: Eighty-four typically-developing 7-to 12-year-old children. Procedure (methods): Participants and a caregiver will participate in 4 sessions. Three sessions will consist of the screening. These sessions will be telephone calls to collect 24-hour diet information that will be used to determine whether they are eligible for the fourth session. Approximately 120 participants will be screened to find 84 participants who are eligible for the fourth session, in which participants will complete a series of tests on the Cambridge Neuropsychological Test Automated Battery (CANTAB) - a touch-screen device that provides computerized versions of standardized cognitive tests. They will also complete a maze task in which they figure out a path through the maze by walking on the correct squares. Brain activity will be recorded using a portable near-infrared spectroscopy (NIRS) system.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Apr 2014
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2014
CompletedFirst Submitted
Initial submission to the registry
July 23, 2014
CompletedFirst Posted
Study publicly available on registry
July 25, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2016
CompletedDecember 16, 2020
December 1, 2020
2.1 years
July 23, 2014
December 11, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
Error (count) and latency (in milliseconds) measures from executive function tasks
For one specific aim, the omega-6 to omega-3 fatty acid ratio will be determined by summing the omega-6 and omega-3 fatty acid levels in plasma and dividing omega-6 fatty acids by omega-3 fatty acids. The calculated ratio will be used to predict error and latency scores on executive function tasks. For a second specific aim, the oxygenated and deoxygenated hemoglobin concentrations from near-infrared spectroscopy (NIRS) measurements will be used to predict the error and latency measures from executive function tasks.
One time with children who are 7-12 years old
Secondary Outcomes (2)
Oxygenated and deoxygenated hemoglobin concentrations from near-infrared spectroscopy (NIRS)
One time with children who are 7-12 years old.
Performance on the Maze as measured by Noldus Ethovision
One time with children who are 7-12 years old
Study Arms (2)
7-9 year olds
These are children who are between 7 and 9 years old when they are tested.
10-12 year olds
These are children who are between 10 and 12 years old when they are tested.
Eligibility Criteria
All participants will be typically-developing, healthy 7-to-12-year-olds who are fluent in English. Every effort will be made to recruit roughly equal numbers of boys and girls. Recruitment will be conducted irrespective of race and ethnicity. An attempt will be made to match the sample to the race and ethnicity of the region: 80% White, 15% African-American, and 5% Native American, Asian, and Other descent.
You may qualify if:
- Typically-developing children 7-12 years old
You may not qualify if:
- Children or parents who do not speak English
- Any diagnosis of a psychological illness
- History of seizures
- History of tobacco exposure during gestation
- History of alcohol exposure during gestation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of North Carolina, Chapel Hilllead
- Sigma Xicollaborator
Study Sites (1)
UNC-Chapel Hill's Nutrition Research Institute
Kannapolis, North Carolina, 28081, United States
Related Publications (3)
Ingol TT, Li R, Boone KM, Rausch J, Klebanoff MA, Turner AN, Yeates KO, Nelin MA, Sheppard KW, Keim SA. Docosahexaenoic and Arachidonic Acid Supplementation of Toddlers Born Preterm Does Not Affect Short-Term Growth or Adiposity. J Nutr. 2019 Dec 1;149(12):2182-2190. doi: 10.1093/jn/nxz115.
PMID: 31187863DERIVEDSheppard KW, Cheatham CL. Omega-6/omega-3 fatty acid intake of children and older adults in the U.S.: dietary intake in comparison to current dietary recommendations and the Healthy Eating Index. Lipids Health Dis. 2018 Mar 9;17(1):43. doi: 10.1186/s12944-018-0693-9.
PMID: 29523147DERIVEDSheppard KW, Cheatham CL. Executive functions and the omega-6-to-omega-3 fatty acid ratio: a cross-sectional study. Am J Clin Nutr. 2017 Jan;105(1):32-41. doi: 10.3945/ajcn.116.141390. Epub 2016 Nov 16.
PMID: 27852615DERIVED
Study Officials
- PRINCIPAL INVESTIGATOR
Carol L Cheatham, Ph.D.
University of North Carolina, Chapel Hill
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor of Psychology & Neuroscience
Study Record Dates
First Submitted
July 23, 2014
First Posted
July 25, 2014
Study Start
April 1, 2014
Primary Completion
May 1, 2016
Study Completion
May 1, 2016
Last Updated
December 16, 2020
Record last verified: 2020-12